3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
9
Polycystic Ovary Syndrome
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Obesity
5
Weight Loss
4
Neoplasms
4
Colonic Neoplasms
4
Prostatic Neoplasms
3
Endometrial Neoplasms
3
Overweight
2
Multiple Endocrine Neoplasia Type 1
2
Malnutrition
2
Lymphoma, Follicular
2
Carcinoma, Intraductal, Noninfiltrating
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcopenia
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Metabolic Syndrome
1
Menstruation Disturbances
1
Medical Oncology
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Radiotherapy
10
fludarabine phosphate
9
Peripheral Blood Stem Cell Transplantation
8
Cyclosporine
7
Cyclophosphamide
7
Busulfan
7
Whole-Body Irradiation
6
Melphalan
6
Radiofrequency Ablation
5
Mycophenolic Acid
5
Filgrastim
5
Antilymphocyte Serum
5
Surveys and Questionnaires
4
Surgical Procedures, Operative
4
Methotrexate
4
Etoposide
4
Drug Therapy
4
Cisplatin
4
fludarabine
3
Radiosurgery
3
Injections
3
Hepatectomy
3
Cord Blood Stem Cell Transplantation
3
thymoglobulin
2
lenvatinib
2
Vinblastine
2
Videotape Recording
2
Thiotepa
2
Standard of Care
2
Sorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Recurrence
×
Diet
×
Clear all
NCT07494201
2026-03-27
MIMICC
Fondazione del Piemonte per l'Oncologia
Phase NA
Recruiting
2,500 enrolled